The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.

about

The effect of PPARγ agonist on SGLT2 and glucagon expressions in alpha cells under hyperglycemia.

Item

http://www.wikidata.org/entity/Q38708422

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The effect of PPARγ agonist on ...... pha cells under hyperglycemia.

@en

type

Item

label

The effect of PPARγ agonist on ...... pha cells under hyperglycemia.

@en

prefLabel

The effect of PPARγ agonist on ...... pha cells under hyperglycemia.

@en

P1476

The effect of PPARγ agonist on ...... pha cells under hyperglycemia.

@en

P2093

B D Rhee

http://www.w3.org/2001/XMLSchema#string

E J Lee

http://www.w3.org/2001/XMLSchema#string

H M Shin

http://www.w3.org/2001/XMLSchema#string

H S Jung

http://www.w3.org/2001/XMLSchema#string

J H Park

http://www.w3.org/2001/XMLSchema#string

M J Kwon

http://www.w3.org/2001/XMLSchema#string

M Kim

http://www.w3.org/2001/XMLSchema#string

S H Lee

http://www.w3.org/2001/XMLSchema#string

T K Kim

http://www.w3.org/2001/XMLSchema#string

T N Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover

Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels.

Relationship of glucagon suppression by insulin and somatostatin to the ambient glucose concentration.

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Dynamics of insulin secretion and the clinical implications for obesity and diabetes

Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains.

Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells.

PPARγ signaling and metabolism: the good, the bad and the future.

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

P2888

s40618-017-0659-1

P31

scholarly article

P356

10.1007/S40618-017-0659-1

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084521130

http://www.w3.org/2001/XMLSchema#string

P698

28391584

http://www.w3.org/2001/XMLSchema#string

P921

hyperglycemia